Anatomy of the pancreas
1: Head of pancreas
2: Uncinate process of pancreas
3: Pancreatic notch
4: Body of pancreas
5: Anterior surface of pancreas
6: Inferior surface of pancreas
7: Superior margin of pancreas
8: Anterior margin of pancreas
9: Inferior margin of pancreas
10: Omental tuber
11: Tail of pancreas
|Latin||Pancreass (Greek: Pankreas)|
|inferior pancreaticoduodenal artery, anterior superior pancreaticoduodenal artery, posterior superior pancreaticoduodenal artery, splenic artery|
|pancreaticoduodenal veins, pancreatic veins|
|pancreatic plexus, celiac ganglia, vagus|
The pancreas // is a glandular organ in the digestive system and endocrine system of vertebrates. In humans, it is located in the abdominal cavity behind the stomach. It is an endocrine gland producing several important hormones, including insulin, glucagon, somatostatin, and pancreatic polypeptide which circulate in the blood. The pancreas is also a digestive organ, secreting pancreatic juice containing digestive enzymes that assist digestion and absorption of nutrients in the small intestine. These enzymes help to further break down the carbohydrates, proteins, and lipids in the chyme.
- 1 Structure
- 2 Function
- 3 Clinical relevance
- 4 History
- 5 Other animals
- 6 Gallery
- 7 See also
- 8 References
- 9 External links
The pancreas is an endocrine organ that lies in the abdomen, specifically the upper left abdomen. It is found behind the stomach, with the head of the pancreas surrounded by the duodenum. The pancreas is about 15cm (6 in) long.
Anatomically, the pancreas is divided into a head, which rests within the concavity of the duodenum, a body lying behind the base of the stomach, and a tail, which ends abutting the spleen. The neck of the pancreas lies between the body and head, and is in front of the superior mesenteric artery and vein. The head of the pancreas surrounds these two vessels, and a small uncinate process emerges from the lower part of the head, lying behind the superior mesenteric artery.
The pancreas is a secretory structure with a internal hormonal role (endocrine) and an external digestive role (exocrine). It has two main ducts, the main pancreatic duct, and the accessory pancreatic duct. These drain enzymes through the ampulla of Vater into the duodenum.
The superior margin of pancreas is blunt and flat to the right; narrow and sharp to the left, near the tail.
It commences on the right in the tuber omentale, and is in relation with the celiac artery, from which the hepatic artery courses to the right just above the gland, while the lienal artery runs toward the left in a groove along this border.
The inferior margin of pancreas separates the posterior from the inferior surface;the superior mesenteric vessels emerge under its right extremity.
The anterior margin of pancreas separates the anterior from the inferior surface of the pancreas, and along this border the two layers of the transverse mesocolon diverge from one another; one passing upward over the anterior surface, the other backward over the inferior surface.
The inferior surface of pancreas is narrow on the right but broader on the left, and is covered by peritoneum; it lies upon the duodenojejunal flexure and on some coils of the jejunum; its left extremity rests on the left colic flexure.
From its upper part it joins to the neck of the pancreas at a well-marked prominence, the tuber omentale which abuts the lesser omentum. Its right limit being marked by a groove for the gastroduodenal artery.
The lower part of the right half, below the transverse colon, is covered by peritoneum continuous with the inferior layer of the transverse mesocolon, and is in contact with the coils of the small intestine.
The superior mesenteric artery passes down in front of the left half across the uncinate process; the superior mesenteric vein runs upward on the right side of the artery and, behind the neck, joins with the lienal vein to form the portal vein.
The pancreas receives blood from branches of both the coeliac artery and superior mesenteric artery. The splenic artery runs along the top margin of the pancreas, and supplies the neck, body and tail of the pancreas through its pancreatic branches, the largest of which is called the greater pancreatic artery. The superior pancreaticoduodenal artery and inferior pancreaticoduodenal artery run along the anterior and posterior surfaces of the head of the pancreas at its border with the duodenum. These supply the head of the pancreas.
The pancreas contains tissue with an endocrine and exocrine role, and this division is also visible when the pancreas is viewed under a microscope.
Darker-staining cells form clusters called acini, which are arranged in lobes separated by a thin fibrous barrier. The secretory cells of each acinus surround a small intercalated duct. Because of their secretory function, these cells have many small granules of zymogens that are visible. The intercalated ducts drains into larger ducts within the lobule, and finally interlobular ducts. The ducts are lined by a single layer of columnar cells. With increasing diameter, several layers of columnar cells may be seen.
The size of the pancreas varies considerably;. Several anatomical variations exist, relating to the embryological development of the two buds of the pancreas. The pancreas develops as two buds on either side of the duodenum. The ventral bud eventually rotates to lie next to the dorsal bud, eventually fusing. If the two buds do not fuse, a pancreas may exist as two separate lobes. This is also called pancreatic divisum. If the ventral bud does not fully rotate, an annular pancreas may exist. This is where sections of the pancreas completely encircle the duodenum, and may even lead to duodenal atresia.
The pancreas forms from the embryonic foregut and is therefore of endodermal origin. Pancreatic development begins [with] the formation of a ventral and dorsal buds, which are the anlages of the pancreas. Each structure communicates with the foregut through a duct. The dorsal pancreatic bud forms the head, body and tail, whereas the ventral pancreatic bud forms the uncinate process.
Differential rotation and fusion of the ventral and dorsal pancreatic buds results in the formation of the definitive pancreas. As the duodenum rotates to the right, it carries with it the ventral pancreatic bud and common bile duct. Upon reaching its final destination, the ventral pancreatic bud fuses with the much larger dorsal pancreatic bud. At this point of fusion, the main ducts of the ventral and dorsal pancreatic buds fuse, forming the main pancreatic duct. The duct of the dorsal bud regresses, leaving the main pancreatic duct.
Differentiation of cells of the pancreas proceeds through two different pathways, corresponding to the dual endocrine and exocrine functions of the pancreas. In progenitor cells of the exocrine pancreas, important molecules that induce differentiation include follistatin, fibroblast growth factors, and activation of the Notch receptor system. Development of the exocrine acini progresses through three successive stages. These are the predifferentiated, protodifferentiated, and differentiated stages, which correspond to undetectable, low, and high levels of digestive enzyme activity, respectively.
Progenitor cells of the endocrine pancreas arise from cells of the protodifferentiated stage of the exocrine pancreas. Under the influence of neurogenin-3 and Isl-1, but in the absence of notch receptor signaling, these cells differentiate to form two lines of committed endocrine precursor cells. The first line, under the direction of a Pax gene, forms α- and γ- cells, which produce glucagon and pancreatic polypeptides, respectively. The second line, influenced by Pax-6, produces beta cells (β-) and delta cells (δ-), which secrete insulin and somatostatin, respectively.
The pancreas is a dual-function gland, having features of both endocrine and exocrine glands.
The part of the pancreas with endocrine function is made up of approximately a million cell clusters called islets of Langerhans. Four main cell types exist in the islets. They are relatively difficult to distinguish using standard staining techniques, but they can be classified by their secretion: α alpha cells secrete glucagon (increase glucose in blood), β beta cells secrete insulin (decrease glucose in blood), Δ delta cells secrete somatostatin (regulates/stops α and β cells) and PP cells, or γ (gamma) cells, secrete pancreatic polypeptide.
The islets are a compact collection of endocrine cells arranged in clusters and cords and are crisscrossed by a dense network of capillaries. The capillaries of the islets are lined by layers of endocrine cells in direct contact with vessels, and most endocrine cells are in direct contact with blood vessels, either by cytoplasmic processes or by direct apposition. According to the volume The Body, by Alan E. Nourse, the islets are "busily manufacturing their hormone and generally disregarding the pancreatic cells all around them, as though they were located in some completely different part of the body." The islets of Langerhans play an imperative role in glucose metabolism and regulation of blood glucose concentration.
The pancreas as an exocrine gland that assists the digestive system. It secretes pancreatic fluid that contains digestive enzymes that pass to the small intestine. These enzymes help to further break down the carbohydrates, proteins and lipids (fats) in the chyme.
In humans, the secretory activity of the pancreas is regulated directly via the effect of hormones in the blood on the islets of Langerhans and indirectly through the effect of the autonomic nervous system on the blood flow.
The exocrine component of the pancreas, often called simply the exocrine pancreas, is the portion of the pancreas that performs exocrine functions. It has ducts that are arranged in clusters called acini (singular acinus). Pancreatic secretions are secreted into the lumen of the acinus, and then accumulate in intralobular ducts that drain to the main pancreatic duct, which drains directly into the duodenum.
Control of the exocrine function of the pancreas is via the hormones gastrin, cholecystokinin and secretin, which are hormones secreted by cells in the stomach and duodenum, in response to distension and/or food and which cause secretion of pancreatic juices.
There are two main classes of exocrine pancreatic secretions:
|Secretion||Cell producing it||Primary signal|
|bicarbonate ions||Centroacinar cells||Secretin|
|digestive enzymes||Basophilic cells||CCK|
The pancreas is also the main source of enzymes for digesting fats (lipids) and proteins. (The enzymes that digest polysaccharides, by contrast, are primarily produced by the walls of the intestines.)
The cells are filled with secretory granules containing the precursor digestive enzymes. The major proteases which the pancreas secretes are trypsinogen and chymotrypsinogen. Secreted to a lesser degree are pancreatic lipase and pancreatic amylase. The pancreas also secretes phospholipase A2, lysophospholipase, and cholesterol esterase.
The precursor enzymes (termed zymogens or proenzymes) are inactive variants of the enzymes; thus autodegradation, which can lead to pancreatitis, is avoided. Once released in the intestine, the enzyme enteropeptidase (formerly, and incorrectly, called enterokinase) present in the intestinal mucosa activates trypsinogen by cleaving it to form trypsin. The free trypsin then cleaves the rest of the trypsinogen, as well as chymotrypsinogen to its active form chymotrypsin.
- Sympathetic (adrenergic)
- α2: decreases secretion from beta cells, increases secretion from alpha cells, β2: increases secretion from beta cells
- Parasympathetic (muscarinic)
- M3: increases stimulation of alpha cells and beta cells
A puncture of the pancreas, which may lead to the secretion of digestive enzymes such as lipase and amylase into the abdominal cavity as well as subsequent pancreatic self-digestion and digestion and damage to organs within the abdomen, generally requires prompt and experienced medical intervention.
Inflammation of the pancreas is known as pancreatitis. Pancreatitis is most often associated with recurrent gallstones or chronic alcohol use, although a variety of other causes, including measles, mumps, the congenital condition alpha-1 antitrypsin deficiency and even some scorpion stings, may cause pancreatitis. Pancreatitis is likely to cause intense pain in the central abdomen, that often radiates to the back, and may be associated with jaundice. In addition, due to causing problems with fat digestion and bilirubin excretion, pancreatitis often presents with pale stools and dark urine.
In pancreatitis, enzymes of the exocrine pancreas damage the structure and tissue of the pancreas. Detection of some of these enyzmes, such as amylase and lipase in the blood, along with symptoms and findings on X-ray, are often used to indicate that a person has pancreatitis. A person with pancreatitis is also at risk of shock. Pancreatitis is often managed medically with analgesics, removal of gallstones or treatment of other causes, and monitoring to ensure a patient does not develop shock.
Pancreatic cancers, particularly the most common type, pancreatic adenocarcinoma, remain very difficult to treat, and are mostly diagnosed only at a stage that is too late for surgery, which is the only curative treatment. Pancreatic cancer is rare in those younger than 40, and the median age of diagnosis is 71. Risk factors include: smoking, obesity, diabetes, and certain rare genetic conditions including: multiple endocrine neoplasia type 1 and hereditary nonpolyposis colon cancer among others. About 25% of cases are attributable to tobacco smoking, while 5-10% of cases are linked to inherited genes.
Pancreatic adenocarcinoma is a cancer of the exocrine part of the pancreas, and there are other types. The many types of pancreatic endocrine tumors are all uncommon or rare, and have varied outlooks. However the incidence of these cancers has been rising sharply; it is not clear to what extent this reflects increased detection, especially through medical imaging, of tumors that would be very slow to develop. Insulinomas (largely benign) and gastrinomas are the most common types. In the United States pancreatic cancer is the fourth most common cause of deaths due to cancer. The disease occurs more often in the developed world, which had 68% of new cases in 2012. Pancreatic adenocarcinoma typically has poor outcomes with the average percentage alive for at least one and five years after diagnosis being 25% and 5% respectively. In localized disease where the cancer is small (< 2 cm) the number alive at five years is approximately 20%. For those with neuroendocrine cancers the number alive after five years is much better at 65%, varying considerably with type.
Diabetes mellitus type 1 (Also known as Juvenile Diabetes) is a chronic autoimmune disorder in which the immune system attacks the insulin-secreting cells in the pancreas. This causes the patient's blood sugar levels to rise to a dangerous level. To correct this, the patient must take 3+ insulin shots per day.
There may be also some correlations between diabetes, chronic pancreatitis and pancreatic cancer.
Diabetes mellitus type 2 is more common among overweight adults, but has been seen in children also. Unlike Type 1, it can be permanently corrected with weight loss and medicine.
It is possible for one to live without a pancreas, provided that the patient takes insulin for proper regulation of blood glucose concentration and pancreatic enzyme supplements to aid digestion.
The pancreas was first identified for western civilization by Herophilus (335–280 BC), a Greek anatomist and surgeon. Only a few hundred years later, Rufus of Ephesus, another Greek anatomist, gave the pancreas its name. Etymologically, the term "pancreas", a modern Latin adaptation of Greek πάγκρεας, [πᾶν ("all", "whole"), and κρέας ("flesh")], originally means sweetbread, although literally meaning all-flesh, presumably because of its fleshy consistency.
Pancreatic tissue is present in all vertebrate species, but its precise form and arrangement vary widely. There may be up to three separate pancreases, two of which arise from ventral buds, and the other dorsally. In most species (including humans), these fuse in the adult, but there are several exceptions. Even when a single pancreas is present, two or three pancreatic ducts may persist, each draining separately into the duodenum (or equivalent part of the foregut). Birds, for example, typically have three such ducts.
In teleosts, and a few other species (such as rabbits), there is no discrete pancreas at all, with pancreatic tissue being distributed diffusely across the mesentery and even within other nearby organs, such as the liver or spleen. In a few teleost species, the endocrine tissue has fused to form a distinct gland within the abdominal cavity, but otherwise it is distributed among the exocrine components. The most primitive arrangement, however, appears to be that of lampreys and lungfish, in which pancreatic tissue is found as a number of discrete nodules within the wall of the gut itself, with the exocrine portions being little different from other glandular structures of the intestine.
- This article uses anatomical terminology; for an overview, see anatomical terminology.
- Physiology at MCG 6/6ch2/s6ch2_30
- Khan, Ali Nawaz. "Chronic Pancreatitis Imaging". Medscape. Retrieved 5 January 2014.
- "Cancer of the Pancreas". NHS. Retrieved 5 November 2014.
- Drake, Richard L.; Vogl, Wayne; Tibbitts, Adam W.M. Mitchell; illustrations by Richard; Richardson, Paul (2005). Gray's anatomy for students. Philadelphia: Elsevier/Churchill Livingstone. pp. 288–290, 297, 303. ISBN 978-0-8089-2306-0.
- Deakin, Barbara Young ...  ; drawings by Philip J. et al. (2006). Wheater's functional histology : a text and colour atlas (5th ed.). [Edinburgh?]: Churchill Livingstone/Elsevier. pp. 299–301. ISBN 978-0-443-06850-8.
- and others (2009). Larsen's human embryology (4th ed., Thoroughly rev. and updated. ed.). Philadelphia: Churchill Livingstone/Elsevier. pp. 241–244. ISBN 978-0-443-06811-9.
|last1=in Authors list (help)
- Carlson, Bruce M. (2004). Human embryology and developmental biology. St. Louis: Mosby. pp. 372–4. ISBN 0-323-01487-9.
- Hellman B, Gylfe E, Grapengiesser E, Dansk H, Salehi A; Gylfe; Grapengiesser; Dansk; Salehi (2007). "[Insulin oscillations--clinically important rhythm. Anti-diabetics should increase the pulsative component of the insulin release]". Lakartidningen (in Swedish) 104 (32–33): 2236–9. PMID 17822201.
- BRS physiology 4th edition ,page 255-256, Linda S. Constanzo, Lippincott publishing
- The Body, by Alan E. Nourse, (op. cit., p. 171.)
- "New Research Redraws Pancreas Anatomy". 7 July 2011.
- Verspohl EJ, Tacke R, Mutschler E, Lambrecht G; Tacke; Mutschler; Lambrecht (1990). "Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies". Eur. J. Pharmacol. 178 (3): 303–311. doi:10.1016/0014-2999(90)90109-J. PMID 2187704.
- Britton, the editors Nicki R. Colledge, Brian R. Walker, Stuart H. Ralston ; illustrated by Robert (2010). Davidson's principles and practice of medicine. (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. pp. 871–874. ISBN 978-0-7020-3085-7.
- Ryan DP, Hong TS, Bardeesy N; Hong; Bardeesy (September 2014). "Pancreatic adenocarcinoma". N. Engl. J. Med. 371 (11): 1039–49. doi:10.1056/NEJMra1404198 (inactive 2014-11-16). PMID 25207767.
- "Pancreatic Cancer Treatment (PDQ®) Patient Version". National Cancer Institute. 2014-04-17. Retrieved 8 June 2014.
- Wolfgang, CL; Herman, JM; Laheru, DA; Klein, AP; Erdek, MA; Fishman, EK; Hruban, RH (Sep 2013). "Recent progress in pancreatic cancer.". CA: a cancer journal for clinicians 63 (5): 319. doi:10.3322/caac.21190. PMID 23856911.
- Burns, WR; Edil, BH (March 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update.". Current treatment options in oncology 13 (1): 24–34. doi:10.1007/s11864-011-0172-2. PMID 22198808.
- Hariharan D, Saied A, Kocher HM; Saied; Kocher (2008). "Analysis of mortality rates for pancreatic cancer across the world". HPB 10 (1): 58–62. doi:10.1080/13651820701883148. PMC 2504856. PMID 18695761.
- World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.7. ISBN 9283204298.
- "American Cancer Society: Cancer Facts & Figures 2010: see page 4 for incidence estimates, and page 19 for survival percentages".
- "Pancreatic Cancer Treatment (PDQ®) Health Professional Version". NCI. 2014-02-21. Retrieved 8 June 2014.
- Braga M., Cristallo M., de Franchis R., Mangiagalli A., Zerbi A., Agape D., Primignani M., di Carlo V. (1989.) Pancreatic enzyme replacement therapy in post-pancreatectomy patients, Int J Pancreatol, 5:S37-44.
- Banks P.A., Conwell D.L., Toskes P.P. (2010.) The management of acute and chronic pancreatitis, Gastroenterol Hepatol, 6(2 Suppl 5):1-16.
- Terry O'Brien. A2Z Book of word Origins. Rupa Publications. p. 86. ISBN 978-81-291-1809-7.
- Harper, Douglas. "Pancreas". Online Etymology Dictionary. Retrieved 2007-04-04.
- Tamara M. Green (2008). The Greek and Latin Roots of English. Rowman & Littlefield. p. 176. ISBN 978-0-7425-4780-3.
- Romer, Alfred Sherwood; Parsons, Thomas S. (1977). The Vertebrate Body. Philadelphia, PA: Holt-Saunders International. pp. 357–359. ISBN 0-03-910284-X.
|Wikimedia Commons has media related to Pancreas.|